Breast Cancer: Targets and Therapy

Código QR

Breast Cancer: Targets and Therapy

Guardado en:

Detalles Bibliográficos
Formato:	journal
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	breast cancer anticancer agents palliative care cancer screening Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/toc/1179-1314
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Palliative care: needs of advanced breast cancer patients
por: Cherny NI, et al.
Publicado: (2018)

Economic analysis of the breast cancer screening program used by the UK NHS: should the program be maintained?
por: Morton R, et al.
Publicado: (2017)

Do Men and Women in Saudi Arabia Have the Same Level of Awareness and Knowledge of Breast Cancer? A Cross-Sectional Study
por: Farsi NJ, et al.
Publicado: (2020)

Breast cancer in Mongolia: an increasingly important health policy issue
por: Demchig D, et al.
Publicado: (2017)

A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Jiaojiao Suo, et al.
Publicado: (2021)

OncoTargets and Therapy
Publicado: (2009)

Interpretation of specification for breast cancer screening, early diagnosis, and treatment management in Chinese women
por: Fei Ma, et al.
Publicado: (2021)

Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women
por: Al-Mousa DS, et al.
Publicado: (2020)

Breast cancer
por: Liudmila G. Zhukova, et al.
Publicado: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia
por: Assefa AA, et al.
Publicado: (2021)

Breast Cancer Screening Practice and Associated Factors Among Women Aged 20–70 Years in Urban Settings of SNNPR, Ethiopia [Corrigendum]
por: Assefa AA, et al.
Publicado: (2021)

Metastasis inhibition in breast cancer by targeting cancer cell extravasation
por: Cominetti MR, et al.
Publicado: (2019)

Artificial intelligence methods for the diagnosis of breast cancer by image processing: a review
por: Sadoughi F, et al.
Publicado: (2018)

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
por: Sambi M, et al.
Publicado: (2017)

Can Naloxegol Therapy Improve Quality of Life in Patients with Advanced Cancer?
por: Rita Ostan, et al.
Publicado: (2021)

Intraoperative radiation therapy for breast cancer patients: current perspectives
por: Dutta SW, et al.
Publicado: (2017)

Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou P, et al.
Publicado: (2017)

Managing breast cancer in younger women: challenges and solutions
por: Ademuyiwa FO, et al.
Publicado: (2015)

Opioids and Breast Cancer Recurrence: A Systematic Review
por: Merlino Lucia, et al.
Publicado: (2021)

Targeting stem cells in the realm of drug-resistant breast cancer
por: Dey P, et al.
Publicado: (2019)

Aggressiveness of care at end of life in patients with high‐grade glioma
por: Rebecca A. Harrison, et al.
Publicado: (2021)

UK Women’s Views of the Concepts of Personalised Breast Cancer Risk Assessment and Risk-Stratified Breast Screening: A Qualitative Interview Study
por: Charlotte Kelley-Jones, et al.
Publicado: (2021)

Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer
por: Kispert S, et al.
Publicado: (2017)

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)

Targeting &gamma;-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)

Statins and risk of breast cancer recurrence
por: Sakellakis M, et al.
Publicado: (2016)

Breast Cancer Screening Practices in a Tertiary Care Center in the State of Qatar: A Cross-Sectional Survey
por: Parambil JV, et al.
Publicado: (2021)

Intensity modulated radiation therapy for breast cancer: current perspectives
por: Buwenge M, et al.
Publicado: (2017)

Decreased risk of breast cancer associated with oral bisphosphonate therapy
por: Mathew A, et al.
Publicado: (2012)

Inhibiting breast cancer by targeting the thromboxane A2 pathway
por: Haitao Li, et al.
Publicado: (2017)

Revisiting the IGF-1R as a breast cancer target
por: Roudy Chiminch Ekyalongo, et al.
Publicado: (2017)

Dietary Factors and Breast Cancer Prognosis among Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sin-Hye Park, et al.
Publicado: (2021)

The role of the chemokine receptor XCR1 in breast cancer cells
por: Yang XL, et al.
Publicado: (2017)

SABR in oligometastatic breast cancer: Current status and future directions
por: Rachel Stewart, et al.
Publicado: (2021)

Mentha arvensis (Linn.)-mediated green silver nanoparticles trigger caspase 9-dependent cell death in MCF7 and MDA-MB-231 cells
por: Banerjee PP, et al.
Publicado: (2017)

Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry
por: Don Thiwanka Wijeratne, et al.
Publicado: (2021)

Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells
por: Chatterjee S, et al.
Publicado: (2015)

Non-small cell lung cancer: the era of targeted therapy
por: Antonoff MB, et al.
Publicado: (2012)

Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
por: Yuan P, et al.
Publicado: (2021)